2026-525696-77-00招募中4 期
A study in healthy people to test how Zongertinib is taken up in the body when given as tablets made by two different manufacturers with or without food
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 56
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CT Disclosure & Data Transparency
Scientific
Boehringer Ingelheim International GmbH
研究点 (3)
Loading locations...
相似试验
已完成
1 期
A study in healthy men to test whether zongertinib influences the amount of 3 other medicines in the blood2023-510263-35-00Boehringer Ingelheim International GmbH16
招募中
2 期
A Study of Zanzalintinib in Participants With Recurrent or Progressive MeningiomaMeningiomaNCT07428616Exelixis100
尚未招募
2 期
Zanzalintinib in Unresectable and Progressive MPGGsPheochromocytomaParagangliomaNCT07714551Dana-Farber Cancer Institute14
招募中
1 期
Zorifertinib With Osimertinib for NSCLC With Meningeal ProgressionNCT07361705Alpha Biopharma (Jiangsu) Co., Ltd.42
尚未招募
2 期
A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory NeuroblastomaMetastatic Olfactory NeuroblastomaNCT07527169M.D. Anderson Cancer Center16